Brian White, MD
Hand Surgery · Orlando, FLNPI 1487889333
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 64.5% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $3,261 and has fallen 92.5% since, to $243 in 2025.
Across 32 payments — averaging $165.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Reel Surgical, Inc.$1K
- Zimmer Biomet$287
- Integra Lifesciences Corporation$105
- Smith+Nephew$44
- Acumed LLC$43
- plus $179 from 8 others
What the payments were for
- Speaking & faculty fees$2,00038%
- Food & beverage$88717%
- Education$2,40045%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 6 | $3,412 |
| Reel Surgical, Inc. | 2 | $1,217 |
| Zimmer Biomet | 7 | $287 |
| Integra Lifesciences Corporation | 5 | $105 |
| Smith+Nephew | 2 | $44 |
| Acumed LLC | 1 | $43 |
| Stryker | 2 | $33 |
| Medtronic | 1 | $33 |
| Carbofix Orthopedics Inc | 1 | $30 |
| Endo USA, Inc. | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Checkpoint Surgical, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,287 in reported general payments places this provider in the 60th percentile of 173 hand surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 58 | $1,208 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 133 | $1,028 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 168 | $844 |
| Celecoxib | 37 | $809 |
| Diclofenac Sodium | 51 | $559 |
| Methylprednisolone | 57 | $343 |
| Cephalexin | 24 | $250 |
| Ibuprofen | 26 | $241 |
| Ondansetron OdtOndansetron | 17 | $138 |
| Tramadol Hcl | 33 | $76 |
| Meloxicam | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Orlando
- Justin ZumstegOrlando$133K
- Brett LewellynOrlando$41K
- Bryan BrownOrlando$27K
- Amir KachooeiOrlando$19K
- Cody HillinOrlando$6K
- Jorge Orbay-CerratoMiami$12.5M
- Peter EvansStuart$525K
- Nirav GuptaOcala$491K
- Francisco RubioMiami$345K
- Maria-Carolina Orbay AranMiami$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.